GLUL and epilepsy: Impairment of lysine metabolism results in elevated brain glutarate levels, inhibiting glutamate decarboxylase, reducing γ-aminobutyric acid (GABA) synthesis, and leading to severe neurological deficits, ultimately causing epilepsy [29,30].